Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells

Cited by (605)

Items 201–300 of 605

1. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes
   Wai Ming Li, Marcel B. Bally, Marie-Paule M Schutze-Redelmeier · 2001 · Vaccine
2. Sequence-Specific Sensing of Nucleic Acids
   Vabret, Nicolas, Bhardwaj, Nina, Greenbaum, Benjamin D. · 2017 · Trends in Immunology
3. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation
   Cornelia Gujer, Christopher Sundling, Robert A. Seder, Gunilla B. Karlsson Hedestam, Karin Loré · 2011 · Immunology
4. Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-κB
   Wiesław Kozak, Sylwia Wrotek, Anna Kozak · 2005 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
5. Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D/A Oligodeoxynucleotides Expressing CpG Motifs
   Barbara J. Flynn, Vivian Ying Wang, David L. Sacks, Robert A. Seder, Daniela I. Verthelyi · 2005 · Infection and Immunity
6. Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant
   Chun-Yen Chu, Chia‐Hui Liu, Jhong-Jie Liou, Jai‐Wei Lee, Li-Ting Cheng · 2014 · Vaccine
7. Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality
   Candy S. Hwang, Paul T. Bremer, Cody J. Wenthur, Sam On Ho, SuMing Chiang, Beverly A. Ellis, Bin Zhou, Gary Fujii, Kim D. Janda · 2018 · Molecular Pharmaceutics
8. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
   Guillem Montamat, Cathy Leonard, Aurélie Poli, Ludger Klimek, Markus W. Ollert · 2021 · Frontiers in Immunology
9. Defective Toll‐like receptor 9‐mediated cytokine production in B cells from Bruton's tyrosine kinase‐deficient mice
   Maroof Hasan, Gabriela López‐Herrera, K. Emelie M. Blomberg, Jessica Margareta Lindvall, Anna Berglöf, C. I. Edvard Smith, Leonardo Vargas · 2007 · Immunology
10. Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA
    L Tasker, Stuart Marshall-Clarke · 2003 · Clinical & Experimental Immunology
11. CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum
    Yan Zhang, Guy H. Palmer, Jeffrey R. Abbott, Chris J. Howard, Jayne C. Hope, Wendy C. Brown · 2003 · Vaccine
12. Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection
    John W. Mapletoft, Mustapha Oumouna, Jennifer Kovacs-Nolan, Laura J. P. Latimer, George Mutwiri, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk · 2007 · Journal of General Virology
13. Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics
    Marina A. Dobrovolskaia, Scott E. McNeil · 2015 · Expert Opinion on Biological Therapy
14. Formulation with CpG Oligodeoxynucleotides Prevents Induction of Pulmonary Immunopathology following Priming with Formalin-Inactivated or Commercial Killed Bovine Respiratory Syncytial Virus Vaccine
    Mustapha Oumouna, John W. Mapletoft, Brenda Karvonen, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk · 2005 · Journal of Virology
15. The in vitro effect of CpG-ODNs on the innate immune response of common carp, Cyprinus carpio L.
    Asmi Citra Malina A.R. Tassakka, Masahiro Sakai · 2003 · Aquaculture
16. TLR9-Mediated Recognition of DNA
    Thomas R Müller, Svetlana Hamm, Stefan Bauer · 2007 · Handbook of experimental pharmacology
17. Adjuvants and inactivated polio vaccine: A systematic review
    Jennifer Hawken, Stephanie B. Troy · 2012 · Vaccine
18. Toll-like receptor 9 agonists as cancer therapeutics
    Udo Holtick, Max Ernst Scheulen, Michael S. von Bergwelt‐Baildon, Martin R. Weihrauch · 2011 · Expert Opinion on Investigational Drugs
19. IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
    Aharon Kessel, Regina Peri, Tharwat Haj, Ayelet Snir, Gleb Slobodin, Edmond Sabo, Itzhak Rosner, Yehuda Shoenfeld, Elias Toubi · 2010 · Journal of Clinical Immunology
20. Structural studies of oligonucleotides containing G-quadruplex motifs using AFM
    L.T Costa, Miren Kerkmann, Gunther Hartmann, Stefan Endres, Paulo M. Bisch, Wolfgang M. Heckl, Stefan Thalhammer · 2003 · Biochemical and Biophysical Research Communications
21. Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside
    Qiuyan Zhao, Dong Su Yu, Sudhir Agrawal · 2000 · Bioorganic & Medicinal Chemistry Letters
22. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9
    Jelka Pohar, Duško Lainšček, Ryutaro Fukui, Chikako Yamamoto, Kensuke Miyake, Roman Jerala, Mojca Benčina · 2015 · The Journal of Immunology
23. Lactobacillus rhamnosus GG components, SLP, gDNA and CpG, exert protective effects on mouse macrophages upon lipopolysaccharide challenge
    S.R. Qi, Yanjun Cui, Jianxin Liu, Xin Luo, Haifeng Wang · 2019 · Letters in Applied Microbiology
24. An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response
    Li Dong, Isamu Mori, M. Jaber Hossain, Beixing Liu, Yoshinobu Kimura · 2003 · Journal of General Virology
25. DNA mucosal HIV vaccine in humans
    Peter Lundholm, Ann-Charlotte Leandersson, Birger Christensson, Göran Bratt, Eric Sandström, Britta Wahrén · 2001 · Virus Research
26. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA
    Keunwook Lee, Jinwon Jung, Younghee Lee, Tae‐Yoon Kim, Soo‐Young Choi, Jinseu Park, Doo‐Sik Kim, Hyung‐Joo Kwon · 2006 · Molecular Immunology
27. Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis
    Rahul Shivahare, Preeti Vishwakarma, Naveen Parmar, Pawan Kumar Yadav, Wahajul Haq, Mrigank Srivastava, Suman Kanti Das Gupta, Susanta Kar · 2014 · PLoS ONE
28. Synthetic oligonucleotides as modulators of inflammation
    Dennis M. Klinman, Hidekazu Shirota, Debra Tross, Takashi Sato, Sven Klaschik · 2008 · Journal of Leukocyte Biology
29. CpG Oligonucleotides Improve the Protective Immune Response Induced by the Licensed Anthrax Vaccine
    Dennis M. Klinman, Hang Xie, Bruce E. Ivins · 2006 · Annals of the New York Academy of Sciences
30. Spontaneous Production of Immunoglobulin M in Human Epithelial Cancer Cells
    Fanlei Hu, Li Zhang, Jie Zheng, Ling Zhao, Jing Huang, Wenwei Shao, Qinyuan Liao, Teng Ma, Li Geng, C. Cameron Yin et al. · 2012 · PLoS ONE
31. HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component
    Lifei Yang, Yufeng Song, Xiaomin Li, Xiaoxing Huang, Jingjing Liu, Heng Ding, Ping Zhu, Paul Zhou · 2012 · Journal of Virology
32. Immunostimulatory Properties of CpG-Oligonucleotides Are Enhanced by the Use of Protamine Nanoparticles
    Miren Kerkmann, Dirk Lochmann, Jörg Weyermann, Anja Marschner, Hendrik Poeck, Moritz Wagner, Julia Battiany, Andreas Zimmer, Stefan Endres, Gunther Hartmann · 2006 · Oligonucleotides
33. CpG oligodeoxynucleotides stimulate immune cell proliferation but not specific antibody production in rainbow trout (Oncorhynchus mykiss)
    Allison C. Carrington, Bertrand Collet, Jason W. Holland, Christopher John Secombes · 2004 · Veterinary Immunology and Immunopathology
34. Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells
    Angelo Mena, Anil Nichani, Yurij Popowych, Dale L. Godson, Donna Dent, Hugh G.G. Townsend, George Mutwiri, Rolf Hecker, Lorne A. Babiuk, Philip John Griebel · 2003 · Immunology
35. Gene Combination Raises Broad Human Immunodeficiency Virus-Specific Cytotoxicity
    Sandra A. Calarota, Anne Kjerrström, Khalid B. Islam, Britta Wahrén · 2001 · Human Gene Therapy
36. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
    Lisl K.M. Shoda, Kimberly A. Kegerreis, Carlos Esteban Suarez, Waithaka Mwangi, Donald P. Knowles, Wendy C. Brown · 2001 · PubMed
37. Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest
    Pavel A. Nikitin, Alexander M. Price, Karyn McFadden, Christopher M. Yan, Micah A. Luftig · 2014 · PLoS ONE
38. Investigating the Effects of a Hydrolytically Stable Hapten and a Th1 Adjuvant on Heroin Vaccine Performance
    Paul T. Bremer, Kim D. Janda · 2012 · Journal of Medicinal Chemistry
39. Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity
    Sapna Trivedi, Eric L. Greidinger · 2009 · Therapy
40. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-α, and NO production by bovine macrophages
    Lisl K.M. Shoda, Kimberly A. Kegerreis, Carlos Esteban Suarez, Waithaka Mwangi, Donald P. Knowles, Wendy C. Brown · 2001 · Journal of Leukocyte Biology
41. Formulations combining CpG containing oliogonucleotides and poly I:C enhance the magnitude of immune responses and protection against pancreas disease in Atlantic salmon
    Guro Strandskog, Stéphane Villoing, Dimitar Borisov Iliev, Hanna L. Thim, Karen Elina Christie, Jorunn B. Jørgensen · 2011 · Developmental & Comparative Immunology
42. Mincle and human B cell function
    Kazuhito Kawata, Petr A. Illarionov, Guoxiang Yang, Thomas P. Kenny, Weici Zhang, Masanobu Tsuda, Yugo Ando, Patrick S.C. Leung, Aftab Ahmed Ansari, Merrill Eric Gershwin · 2012 · Journal of Autoimmunity
43. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle
    Rong Liang, J V van den Hurk, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk · 2006 · Journal of General Virology
44. Heterogeneity in the Human Response to Immunostimulatory CpG Oligodeoxynucleotides
    Cynthia Anne Leifer, Daniela I. Verthelyi, Dennis M. Klinman · 2003 · Journal of Immunotherapy
45. Hsp90 binds CpG oligonucleotides directly: implications for Hsp90 as a missing link in CpG signaling and recognition
    Lisa Bandholtz, Yurong Guo, Carina Palmberg, K. Mattsson, B. Ohlsson, Anthony A. High, Jeffrey Shabanowitz, Donald F. Hunt, Henrik Jörnvall, Hans Wigzell et al. · 2003 · Cellular and Molecular Life Sciences
46. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ‘lasso’ for the multi-faced virus
    Volodymyr Volodymyrovych Oberemok, Kateryna Volodymyrivna Laikova, Kseniya A. Yurchenko, N. A. Marochkin, И. И. Фомочкина, Anatoly Vladimirovich Kubyshkin · 2020 · Inflammation Research
47. Characterization of three distinct CpG oligonucleotide classes which differ in ability to induce IFN α/β activity and cell proliferation in Atlantic salmon (Salmo salar L.) leukocytes
    Guro Strandskog, Terje Ellingsen, Jorunn B. Jørgensen · 2006 · Developmental & Comparative Immunology
48. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides
    Thomas W. Decker, Susanne Hipp, Robert J. Kreitman, Ira H Pastan, Christian Peschel, Thomas Licht · 2002 · Blood
49. TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects
    Michele Sommariva, Loris De Cecco, Michelandrea De Cesare, Lucia Sfondrini, Sylvie Ménard, Cecilia C. Melani, Domenico Delia, Nadia Zaffaroni, Graziella Pratesi, Valentina Uva et al. · 2011 · Cancer Research
50. A Novel Function of Phosphorothioate Oligodeoxynucleotides as Chemoattractants for Primary Macrophages
    Kwan Hyuck Baek, Sang‐Jun Ha, Young Chul Sung · 2001 · The Journal of Immunology
51. Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation
    Hsin-Jung Joyce Wu, Chandrasekar Venkataraman, Steven Estus, Chen Dong, Roger J. Davis, Richard Anthony Flavell, Subbarao Bondada · 2001 · The Journal of Immunology
52. Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates
    Alireza Hassani Najafabadi, Zeynab Izadi Najafabadi, Marisa E. Aikins, Kathryn E. Foulds, Mitzi M. Donaldson, Wenmin Yuan, Emeka Benjamin Okeke, Jutaek Nam, Yao Xu, Priyan D. Weerappuli et al. · 2021 · Journal of Controlled Release
53. CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response
    Gregor S. D. Reid, Kevin She, Luke Terrett, Michael R. Food, Jacqueline D. Trudeau, Kirk R. Schultz · 2005 · Blood
54. Identification of two subpopulations of purified human blood B cells, CD27− CD23+ and CD27high CD80+, that strongly express cell surface Toll‐like receptor 9 and secrete high levels of interleukin‐6
    Fabrice Cognasse, Hind Hamzeh‐Cognasse, Sandrine T. Lafarge, Patricia Chavarin, Bruno Pozzetto, Yolande Richard, Olivier Garraud · 2008 · Immunology
55. Structure–Activity Relationship Studies on the Immune Stimulatory Effects of Base‐Modified CpG Toll‐Like Receptor 9 Agonists
    Marion Jurk, Andrea Kritzler, Harald Debelak, Jörg Vollmer, Arthur Μ. Krieg, Eugen Uhlmann · 2006 · ChemMedChem
56. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody productionin vitro
    Nikola Lepse, Judith Land, Abraham Rutgers, Cees G. M. Kallenberg, Coen A. Stegeman, Wayel Habib Abdulahad, Peter Heeringa · 2015 · Lara D. Veeken
57. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides
    Huijie Zhang, Shini Feng, Ting Yan, Chunyi Zhi, Xiao‐Dong Gao, Nobutaka Hanagata · 2015 · International Journal of Nanomedicine
58. Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function
    Driss El Kebir, Levente József, János G. Filep · 2008 · Archivum Immunologiae et Therapiae Experimentalis
59. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus
    John W. Mapletoft, Mustapha Oumouna, Hugh G.G. Townsend, Susantha M. Gomis, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk · 2006 · Virology
60. Single-Stranded Oligonucleotides Can Inhibit Cytokine Production Induced by Human Toll-Like Receptor 3
    C. T. Ranjith-Kumar, Karen E. Duffy, Jarrat L. Jordan, Ashlyn Eaton Bassiri, Robert C. Vaughan, Scott A. Hoose, Roberta J. Lamb, Robert T. Sarisky, C. Cheng Kao · 2008 · Molecular and Cellular Biology
61. Epigenetic analysis of HIV-1 proviral genomes from infected individuals: Predominance of unmethylated CpG's
    Stefanie Weber, Barbara Weiser, Kimdar Sherefa Kemal, Harold Burger, Christina M. Ramirez, Klaus Korn, Kathryn Anastos, Rupert Kaul, Colin C. Kovacs, Walter Doerfler · 2013 · Virology
62. Intranasal Immunization of Mice with a Bovine Respiratory Syncytial Virus Vaccine Induces Superior Immunity and Protection Compared to Those by Subcutaneous Delivery or Combinations of Intranasal and Subcutaneous Prime-Boost Strategies
    John W. Mapletoft, Laura J. P. Latimer, Lorne A. Babiuk, Sylvia van Drunen Littel‐van den Hurk · 2009 · Clinical and Vaccine Immunology
63. Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding
    Robert F. Ashman, J. Adam Goeken, Eicke Latz, Petar S. Lenert · 2011 · International Immunology
64. CpG Oligodeoxynucleotides Modulate Innate and Adaptive Functions of IgM+ B Cells in Rainbow Trout
    Rocío Simón, Patricia Díaz‐Rosales, Esther Morel, Diana L Martin, Aitor G. Granja, Carolina Tafalla · 2019 · Frontiers in Immunology
65. Activation of Innate Immunity by Therapeutic Nucleic Acids
    Ali Bishani, Elena L. Chernolovskaya · 2021 · International Journal of Molecular Sciences
66. Beyond Double-Stranded RNA-Type I IFN Induction by 3pRNA and Other Viral Nucleic Acids
    Martin Schlee, Winfried Barchet, Veit Hornung, Gunther Hartmann · 2007 · Current topics in microbiology and immunology
67. Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration
    Bernhard O. Noll, Michael J. McCluskie, Tanja Sniatala, Angela Lohner, Stephanie Yuill, Arthur Μ. Krieg, Christian Schetter, Heather L. Davis, Eugen Uhlmann · 2005 · Biochemical Pharmacology
68. Characterization of a Human Platelet Antigen-1a–Specific Monoclonal Antibody Derived from a B Cell from a Woman Alloimmunized in Pregnancy
    Mariana Eksteen, Heidi Tiller, Maria Averina, Gøril Heide, Mette Kjær, Cédric Ghevaert, Terje Einar Michaelsen, Øistein Ihle, Anne Husebekk, Bjørn R. Skogen et al. · 2015 · The Journal of Immunology
69. Nucleic Acids Exert a Sequence-independent Cooperative Effect on Sequence-dependent Activation of Toll-like Receptor 9
    Jason Kindrachuk, Jean E. Potter, Robert M. Brownlie, Andrew Ficzycz, Philip John Griebel, Neeloffer Mookherjee, George Mutwiri, Lorne A. Babiuk, Scott Napper · 2007 · Journal of Biological Chemistry
70. A Proviral Role for CpG in Cytomegalovirus Infection
    Ann‐Charlotte Iversen, Bjørg Steinkjer, Nadra J. Nilsen, Janne Ø. Bohnhorst, Siv Helen Moen, Randi Vik, Phil J. Stephens, David Wayne Thomas, Chris A. Benedict, Terje Espevik · 2009 · The Journal of Immunology
71. Understanding TLR9 action in Epstein-Barr virus infection
    Ludwig Zauner · 2011 · Frontiers in bioscience
72. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients
    Weronika Rudnicka, Tomasz Burakowski, Ewa Kuca‐Warnawin, Magdalena Jastrzębska, Magdalena Bik, Ewa Kontny, M. Chorazy-Massalska, Anna Radzikowska, Marcin Buler, Paweł Małdyk et al. · 2009 · European Journal of Immunology
73. HPV DNA vaccines
    T.‐C. Wu · 2003 · Frontiers in bioscience
74. Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotides
    Katharina Tschoep, Gunther Hartmann, Ralf Jürgen Jox, Steffi Thompson, Andreas Eigler, Anne Krug, Simon Erhardt, Gerhard Adams, Stefan Endres, Michael Delius · 2001 · Journal of Molecular Medicine
75. NF-κB-dependent regulation of tumor necrosis factor-α gene expression by CpG-oligodeoxynucleotides
    Hyung‐Joo Kwon, Keunwook Lee, Sangho Yu, Jung Ho Han, Doo‐Sik Kim · 2003 · Biochemical and Biophysical Research Communications
76. CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
    N. William Parilla, Valerie S. Hughes, Kristin M. Lierl, Hector R. Wong, Kristen Page · 2006 · Respiratory Research
77. Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells
    Franziska Römmler, Monika Hammel, Anna Waldhuber, Tina Müller, Marion Jurk, Eugen Uhlmann, Hermann Wagner, Jörg Vollmer, Thomas Miethke · 2015 · PLoS ONE
78. Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells
    Jason D. Marshall · 2003 · Nucleic Acids Research
79. Overcoming the Inflammatory Toxicity of Cationic Gene Vectors
    Yadi Tan, Leaf Huang · 2002 · Journal of drug targeting
80. Emerging nanoparticle platforms for CpG oligonucleotide delivery
    Mingqiang Li, Haochen Yao, Ke Yi, Yeh‐Hsing Lao, Dan Shao, Yu Tao · 2024 · Biomaterials Science
81. DNA vaccines against tuberculosis
    Nicolas Bruffaerts, Kris Huygen, Márta Romano · 2014 · Expert Opinion on Biological Therapy
82. Novel Immunostimulatory Agent Based on CpG Oligodeoxynucleotide Linked to the Nontoxic B Subunit of Cholera Toxin
    Jenni Adamsson, Marianne Lindblad, Annika Lundqvist, Denise Kelly, Jan R. Holmgren, Ali M. Harandi · 2006 · The Journal of Immunology
83. Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs
    Philip J. Hogarth, Keith Jahans, Rolf Hecker, R. Glyn Hewinson, Mark Andrew Chambers · 2003 · Vaccine
84. Characterization of human FCRL4-positive B cells
    Michel Jourdan, Nicolas Robert, Maïlys Cren, Coraline Thibaut, Christophe Duperray, Alboukadel Kassambara, Michel Cogné, Karin Tarte, Bernard Klein, Jérôme Moreaux · 2017 · PLoS ONE
85. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus
    Chunting Yang, Huiying Shi, Jun Zhou, Yanwen Liang, Honglin Xu · 2009 · Vaccine
86. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice
    Ying Liu, Xing Luo, Chunting Yang, San-Ke Yu, Honglin Xu · 2011 · Vaccine
87. Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNA
    Christoph Coch, Nicolas Busch, Vera Wimmenauer, Evelyn Hartmann, Markus Janke, Mona M.A. Abdel-Mottaleb, Alf Lamprecht, János Ludwig, Winfried Barchet, Martin Schlee et al. · 2009 · Journal of Leukocyte Biology
88. TLR9-Activating DNA Up-Regulates ZAP70 via Sustained PKB Induction in IgM+ B Cells
    Isabelle Bekeredjian‐Ding, Anne Doster, Martin R. Schiller, Petra Heyder, Hanns‐Martin Lorenz, Burkhart L. Schraven, Ursula Bommhardt, Klaus M. Heeg · 2008 · The Journal of Immunology
89. CpG Motifs as Possible Adjuvants for the Treatment of Allergic Diseases
    Barbara Bohle · 2002 · International Archives of Allergy and Immunology
90. Peritumoral CpG Oligodeoxynucleotide Treatment Inhibits Tumor Growth and Metastasis of B16F10 Melanoma Cells
    Nagisa Kunikata, Kunio Sano, Motoko Honda, Kuniaki Ishii, Jun Matsunaga, Ryuhei Okuyama, Kazuhiro Takahashi, Hiroshi K. Watanabe, Gen Tamura, Hachiro Tagami et al. · 2004 · Journal of Investigative Dermatology
91. B Cell‐Activating Factor Enhances Interleukin‐6 and Interleukin‐10 Production by ODN‐Activated Human B Cells
    Dana Yehudai, Ayelet Snir, Regina Peri, Katalin Halasz, Tharwat Haj, M. Odeh, Aharon Kessel · 2012 · Scandinavian Journal of Immunology
92. Interaction of B cells with intracellular pathogen Francisella tularensis
    Zuzana Kročová, Anetta Härtlová, Dagmar Součková, Lucie Živná, Michal Kroča, Emil Rudolf, Aleš Macela, Jiří Stulík · 2008 · Microbial Pathogenesis
93. Epithelial cells are a source of natural IgM that contribute to innate immune responses
    Wenwei Shao, Fanlei Hu, Junfan Ma, Chi Zhang, Qinyuan Liao, Zhu Zhu, Enyang Liu, Xiaoyan Qiu · 2016 · The International Journal of Biochemistry & Cell Biology
94. Immunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells
    Darya Alizadeh, Ethan E. White, Teresa C. Sanchez, Shunan Liu, Leying Zhang, Behnam Badie, Jacob M. Berlin · 2018 · Bioconjugate Chemistry
95. Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants
    Qi Qiu, Richard Yuan-Hu Wang, Xuanmao Jiao, Bo Jin, Fuminaka Sugauchi, Teresa Grandinetti, Harvey J. Alter, James Wai-kuo Shih · 2008 · Vaccine
96. Oxidized DNA induces an adaptive response in human fibroblasts
    Svetlana V. Kostyuk, Vyacheslav Yu. Tabakov, Valerij V. Chestkov, Marina S. Konkova, Kristina V. Glebova, Galina Baydakova, Elizaveta Sergeevna Ershova, Vera Leonidovna Izhevskaya, Ancha V. Baranova, Natalia Nikolaevna Veiko · 2013 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
97. Genuine Immunomodulation With dSLIM
    Kerstin Kapp, Christiane Kleuss, Matthias Schroff, Burghardt Wittig · 2014 · Molecular Therapy — Nucleic Acids
98. Extracellular DNA Fragments
    Aleksei V. Ermakov, Svetlana V. Kostyuk, Marina S. Konkova, Natalya A. Egolina, Elena M. Malinovskaya, Н. Н. Вейко · 2008 · Annals of the New York Academy of Sciences
99. Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response
    Sebastien A. Burel, Todd Machemer, Frank L. Ragone, Hiroki Kato, Patrick Cauntay, Sarah Greenlee, Aneeza Salim, William A. Gaarde, Gene Hung, Raechel Q. Peralta et al. · 2012 · Journal of Pharmacology and Experimental Therapeutics
100. Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application
     Ling Bai, Wei Chen, Jingtao Chen, Wei Li, Lei Zhou, Chao Shi Niu, Wei Han, Jiuwei Cui · 2017 · Journal of Translational Medicine